• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation.

作者信息

Sawyer R G, Adams R B, Pruett T L

机构信息

Department of Surgery, University of Virginia Surgical Infectious Disease Laboratory, Charlottesville.

出版信息

Am Surg. 1994 Nov;60(11):849-53.

PMID:7978680
Abstract

The activity of gentamicin is known to be decreased in acidic environments, and both the peritoneum during peritonitis and the interior of abscesses have been shown to be acidic and hypoxic. The activity of beta-lactam antibiotics is felt to be relatively less diminished under the same circumstances. We determined that the minimum inhibitory concentration of gentamicin against one pathogenic strain of Escherichia coli increased eight-fold, to 8 mugm/mL, when testing conditions were changed from normoxic and neutral to hypoxic and acidic, whereas the MIC of aztreonam doubled under the same conditions, to 0.25 mugm/mL. In further experiments in a murine model of mixed Escherichia coli/Bacteroides fragilis intra-abdominal abscesses, we demonstrated that a combination of aztreonam and clindamycin was superior to a combination of gentamicin and clindamycin in terms of completely preventing abscess formation (33% vs. 0%) and eliminating Escherichia coli from abscesses that did form (100% vs. 61%).

摘要

相似文献

1
Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation.
Am Surg. 1994 Nov;60(11):849-53.
2
Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
J Antimicrob Chemother. 1989 Mar;23(3):383-8. doi: 10.1093/jac/23.3.383.
3
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.白色念珠菌在实验性真菌/细菌性腹膜炎发病机制及脓肿形成中的作用。
Am Surg. 1995 Aug;61(8):726-31.
4
Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.重组组织型纤溶酶原激活剂对弥漫性腹膜炎大鼠腹腔脓肿形成的影响。
J Am Coll Surg. 1994 Oct;179(4):407-11.
5
Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.白色念珠菌及白色念珠菌/大肠杆菌/脆弱拟杆菌腹腔脓肿模型的建立及真菌诱导的细菌易位的证明
J Med Vet Mycol. 1995 Jan-Feb;33(1):49-52.
6
Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.预防性抗生素对脆弱拟杆菌混合感染的影响。
Surg Gynecol Obstet. 1987 Dec;165(6):491-5.
7
Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
Arch Surg. 1986 Feb;121(2):163-8. doi: 10.1001/archsurg.1986.01400020049005.
8
Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.腹腔内感染模型中大肠杆菌与脆弱拟杆菌之间的相互协同作用。
J Med Microbiol. 1989 Aug;29(4):269-76. doi: 10.1099/00222615-29-4-269.
9
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.新型喹诺酮类药物曲伐沙星(CP-99,217)对脆弱拟杆菌和大肠杆菌所致实验性腹腔脓肿的体内疗效。
Antimicrob Agents Chemother. 1997 Mar;41(3):583-6. doi: 10.1128/AAC.41.3.583.
10
Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.儿童社区获得性腹腔内感染的细菌学及抗生素敏感性
J Microbiol Immunol Infect. 2006 Jun;39(3):249-54.

引用本文的文献

1
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles.抗生素在脓肿中的渗透:脓液中测定的磷霉素水平及模拟的浓度-时间曲线
Antimicrob Agents Chemother. 2005 Nov;49(11):4448-54. doi: 10.1128/AAC.49.11.4448-4454.2005.